GS-0201

N/A

Report date: 2024/06/27 17:58:07

NME

Base Information

Drug NameGS-0201

Drug Alias NameGS-0201

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors

TargetsPoly (ADP-Ribose) polymerase 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIsrael

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A